Sustainable Innovation: Drivers and Barriers. e-Therapeutics’ CEO Prof. Malcolm Young shares his perspective.




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Sustainable Innovation: Drivers and Barriers. e-Therapeutics’ CEO Prof. Malcolm Young shares his perspective.
Released on: June 26, 2013. © PharmaTelevision Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this episode of PharmaTelevision News Review, filmed at BioTrinity 2013, Newbury UK, Fintan Walton speaks to Malcolm Young, CEO of e-Therapeutics.
  • Summary
  • Transcript
  • Participants
  • Company
In this episode of PharmaTelevision News Review, filmed at BioTrinity 2013, Newbury UK, Fintan Walton speaks to Malcolm Young, CEO of e-Therapeutics.
In this episode of PharmaTelevision News Review, filmed at BioTrinity 2013, Newbury UK, Fintan walton speaks to Malcolm Young, CEO of e-Therapeutics.
Malcolm Young
e-Therapeutics
e-Therapeutics
e-Therapeutics was founded in 2001 and listed on the AIM market of the London Stock Exchange in 2007. A drug discovery and development company, its mission is to apply network pharmacology to find new treatments for human disease. The Company has a clinical pipeline and is seeking new candidates for development at its Network Pharmacology Centre near Oxford.